Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer

Cancer Medicine

Volumn 4, Issue 5, 2015, Pages 633-642

  Rollakanti, Kishore R ^a,b   Anand, Sanjay ^b,c   Maytin, Edward V ^a,b,c  

^a Cleveland State University   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Department of Dermatology ^*  (United States)

Author keywords

Aminolevulinic acid; Breast cancer; Calcitriol; Cutaneous metastasis; Photodynamic therapy; Vitamin D

Indexed keywords

AMINOLEVULINIC ACID; CALCITRIOL; PROTOPORPHYRIN; PHOTOSENSITIZING AGENT; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOMA; CANCER CONTROL; CANCER REGRESSION; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; METASTASIS; MOUSE; NEOPLASM; NON INVASIVE PROCEDURE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR CELL; TUNEL ASSAY; ANIMAL; BREAST NEOPLASMS; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; REPORTER GENE; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENES, REPORTER; HUMANS; MICE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; VITAMIN D; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85006201908     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.361     Document Type: Article

References (42)

1. American Cancer Society. 2013. What are the key statistics about breast cancer? Available at http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-key-statistics (accessed 07 January 2014).
2. Stevanovic, A., P. Lee, and N. Wilcken . 2006. Metastatic breast cancer. Aust. Fam. Physician 35:309-312.
3. Moore, S. 2002. Cutaneous metastatic breast cancer. Clin. J. Oncol. Nurs. 6:255-260.
4. Gonzalez-Angulo, A. M., F. Morales-Vasquez, and G. N. Hortobagyi . 2007. Overview of resistance to systemic therapy in patients with breast cancer. Adv. Exp. Med. Biol. 608:1-22.
5. Shackley, D. C., C. Whitehurst, N. W. Clarke, C. Betts, and J. V. Moore . 1999. Photodynamic therapy. J. R. Soc. Med. 92:562-565.
6. Dougherty, T. J., G. Lawrence, J. H. Kaufman, D. Boyle, K. R. Weishaupt, and A. Goldfarb . 1979. Photoradiation in the treatment of recurrent breast carcinoma. J. Natl. Cancer Inst. 62:231-237.
7. Schuh, M., U. O. Nseyo, W. R. Potter, T. L. Dao, and T. J. Dougherty . 1987. Photodynamic therapy for palliation of locally recurrent breast carcinoma. J. Clin. Oncol. 5:1766-1770.
8. Sperduto, P. W., T. F. DeLaney, G. Thomas, Smith, P., Dachowski, L. J., Russo, A., et al. 1991. Photodynamic therapy for chest wall recurrence in breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 21:441-446.
9. Khan, S. A., T. J. Dougherty, and T. S. Mang . 1993. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur. J. Cancer 29A:1686-1690.
10. Koren, H., G. Alth, G. M. Schenk, and R. H. Jindra . 1994. Photodynamic therapy-an alternative pathway in the treatment of recurrent breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 28:463-466.
11. Allison, R., T. Mang, G. Hewson, W. Snider, and D. Dougherty . 2001. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer 91:1-8.
12. Cuenca, R. E., R. R. Allison, C. Sibata, and G. H. Downie . 2004. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann. Surg. Oncol. 11:322-327.
13. Juzeniene, A., Q. Peng, and J. Moan . 2007. Milestones in the development of photodynamic therapy and fluorescence diagnosis. Photochem. Photobiol. Sci. 6:1234-1245.
14. Anand, S., B. J. Ortel, S. P. Pereira, T. Hasan, and E. V. Maytin . 2012. Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Lett. 326:8-16.
15. Rollakanti, K. R., S. C. Kanick, S. C. Davis, B. W. Pogue, and E. V. Maytin . 2013. Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy. Photonics Lasers Med. 2:287-303.
16. Tsai, T., R. L. Hong, J. C. Tsai, P. J. Lou, I. F. Ling, and C. T. Chen . 2004. Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells. Lasers Surg. Med. 34:62-72.
17. Alvarez, M. G., M. S. Lacelli, V. Rivarola, A. Batlle, and H. Fukuda . 2007. 5-aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells. J. Environ. Pathol. Toxicol. Oncol. 26:75-82.
18. Feuerstein, T., G. Berkovitch-Luria, A. Nudelman, A. Rephaeli, and Z. Malik . 2011. Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug. Photochem. Photobiol. Sci. 10:1926-1933.
19. Dorward, A. M., K. S. Fancher, T. M. Duffy, W. G. Beamer, and H. Walt . 2005. Early neoplastic and metastatic mammary tumours of transgenic mice detected by 5-aminolevulinic acid-stimulated protoporphyrin IX accumulation. Br. J. Cancer 93:1137-1143.
20. Navone, N. M., C. F. Polo, A. L. Frisardi, N. E. Andrade, and A. M. Battle . 1990. Heme biosynthesis in human breast cancer-mimetic "in vitro" studies and some heme enzymic activity levels. Int. J. Biochem. 22:1407-1411.
21. Ladner, D. P., R. A. Steiner, J. Allemann, U. Haller, and H. Walt . 2001. Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid. Br. J. Cancer 84:33-37.
22. Frei, K. A., H. M. Bonel, H. Frick, H. Walt, and R. A. Steiner . 2004. Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer. Br. J. Cancer 90:805-809.
23. Liu, Y., G. Hou, X. Zhang, J. J. Liu, S. Zhang, and J. Zhang . 2014. A pilot randomized clinical study of the additive treatment effect of photodynamic therapy in breast cancer patients with chest wall recurrence. J. Breast Cancer 17:161-166.
24. Ortel, B., N. Chen, J. Brissette, G. P. Dotto, E. Maytin, and T. Hasan . 1998. Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. Br. J. Cancer 77:1744-1751.
25. Anand, S., C. Wilson, T. Hasan, and E. V. Maytin . 2011. Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. Cancer Res. 71:6040-6050.
26. Sato, N., B. W. Moore, S. Keevey, J. A. Drazba, T. Hasan, and E. V. Maytin . 2007. Vitamin D enhances ALA-induced protoporphyrin IX production and photodynamic cell death in 3-D organotypic cultures of keratinocytes. J. Invest. Dermatol. 127:925-934.
27. Zhang, L., K. E. Hellstrom, and L. Chen . 1994. Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin. Exp. Metastasis 12:87-92.
28. Maguire, C. A., M. S. Bovenberg, M. H. Crommentuijn, J. M. Niers, M. Kerami, J. Teng . 2013. Triple bioluminescence imaging for in vivo monitoring of cellular processes. Mol. Ther. Nucleic Acids 2:e99.
29. Moriyama, E. H., S. K. Bisland, L. Lilge, and B. C. Wilson . 2004. Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy. Photochem. Photobiol. 80:242-249.
30. Anand, S., G. Honari, T. Hasan, P. Elson, and E. V. Maytin . 2009. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin. Cancer Res. 15:3333-3343.
31. Anand, S., K. R. Rollakanti, R. L. Horst, T. Hasan, and E. V. Maytin . 2014. Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma. Photochem. Photobiol. 90:1126-1135.
32. Contag, C. H., S. D. Spilman, P. R. Contag, B. Eames, M. Oshiro, P. Dennery . 1997. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66:523-531.
33. McElroy, W. D., H. H. Seliger, and E. H. White . 1969. Mechanism of bioluminescence, chemiluminescence and enzyme function in the oxidation of firefly luciferin. Photochem. Photobiol. 10:153-170.
34. Jenkins, D. E., Y. S. Hornig, Y. Oei, J. Dusich, and T. Purchio . 2005. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res. 7:R444-R454.
35. Kennedy, J. C., and R. H. Pottier . 1992. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol., B 14:275-292.
36. Hadnagy, A., R. Beaulieu, and D. Balicki . 2008. Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics. Mol. Cancer Ther. 7:740-748.
37. Prabhakaran, P., F. Hassiotou, P. Blancafort, and L. Filgueira . 2013. Cisplatin induces differentiation of breast cancer cells. Front. Oncol. 3:134.
38. Anand, S., T. Hasan, and E. V. Maytin . 2013. Mechanism of differentiation-enhanced photodynamic therapy for cancer: upregulation of coproporphyrinogen oxidase by C/EBP transcription factors. Mol. Cancer Ther. 12:1638-1650.
39. Wyld, L., O. Smith, J. Lawry, M. W. Reed, and N. J. Brown . 1998. Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro. Br. J. Cancer 78:50-55.
40. Loh, C. S., A. J. MacRobert, J. Bedwell, J. Regula, N. Krasner, and S. G. Bown . 1993. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br. J. Cancer 68:41-51.
41. Rick, K., R. Sroka, H. Stepp, M. Kriegmair, R.M. Huber, K. Jacob . 1997. Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J. Photochem. Photobiol., B 40:313-319.
42. Hinnen, P., F. W. de Rooij, W. C. Hop, A. Edixhoven, H. van Dekken, J. H. Wilson . 2002. Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus. J. Photochem. Photobiol., B 68:8-14.